Phillips, Christine2009-06-162010-12-202009-06-162010-12-20PLoS Medicine 3.4 (2006): e1821549-12771549-1676http://hdl.handle.net/10440/483http://digitalcollections.anu.edu.au/handle/10440/483Over the last twenty years, attention deficit hyperactivity disorder (ADHD) has emerged as a disorder of importance in childhood. Prescription of psychostimulants for ADHD escalated in many countries through the 1990s.3 pagesThis is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Keywords: amphetamine; methylphenidate; central stimulant agent; attention deficit disorder; consumer health information; cost benefit analysis; disruptive behavior; drug industry; drug information; drug use; dyslexia; health program; human; information center; inf2006-04-1110.1371/journal.pmed.00301822015-12-08